Skip to main content
logo
Insight Molecular Diagnostics Inc. (IMDX)
NASDAQ: IMDX · Real-Time Price · USD
6.01
+0.34 (6.00%)
At close: Feb 27, 2026, 4:00 PM EST
6.00
-0.01 (-0.12%)
After-hours: Feb 27, 2026, 4:10 PM EST

IMDX Revenue

Insight Molecular Diagnostics had revenue of $260.00K in the quarter ending September 30, 2025, with 126.09% growth. This brings the company's revenue in the last twelve months to $4.40M, up 520.87% year-over-year. In the year 2024, Insight Molecular Diagnostics had annual revenue of $1.88M with 25.15% growth.

Revenue (ttm)
$4.40M
Revenue Growth
+520.87%
P/S Ratio
43.92
Revenue / Employee
$89,837
Employees
49
Market Cap
193.32M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20241.88M378.00K25.15%
Dec 31, 20231.50M545.00K56.89%
Dec 31, 2022958.00K-1.24M-56.41%
Dec 31, 20212.20M982.00K80.76%
Dec 31, 20201.22M--
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Myriad Genetics824.50M
OPKO Health606.88M
Fulgent Genetics315.55M
FONAR106.03M
MDxHealth103.07M
Prenetics Global92.39M
Biodesix80.17M
Burning Rock Biotech75.75M
Revenue Rankings

IMDX News

More News